Summary
Early animal studies found fluminorex roughly equipotent with d-amphetamine as an anorectic. No modern human studies exist; dose guidance is extrapolated from historic aminorex prescriptions and recreational 4-methylaminorex reports. Aminorex analogues have been linked to pulmonary arterial hypertension after chronic use, so strict cycle limits (under two weeks continuous) and cardiovascular screening are prudent. The lipophilic CF₃ group may lengthen elimination half-life and promote accumulation. Reagent-test cross-reactions are unreliable—confirm identity with GC-MS or multi-step reagent testing.
Dose Information
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Oral | 20-40 min | 30-60 min | 1-3 hrs | 4-6 hrs | 24 hrs |
| Insufflated | 5-10 min | 15-30 min | 1-3 hrs | 4-6 hrs | 24 hrs |
| Vaporized / Smoked | 1-5 min | 5-15 min | 1-3 hrs | 4-6 hrs | 24 hrs |
Tolerance
Build-up
develops over days to weeks of regular use
Reset
3–7 days for acute; 1–3 weeks for full reset
Effects
Positive
- Stimulation
- Increased energy
Negative
- Teeth grinding
- Increased heart rate
- Vasoconstriction
- Pupil dilation
- Increased blood pressure
- Insomnia
- Increased perspiration
- Bruxism
Positive
- Motivation enhancement
- Focus enhancement
- Euphoria
- Wakefulness
- Increased sociability
Negative
- Anxiety
- Irritability
- Compulsive redosing
- Talkativeness
- Thought acceleration
Positive
- Increased libido
- Increased music appreciation
- Visual enhancement
- Tactile enhancement
Negative
- Appetite suppression
- Dehydration
- Light sensitivity
- Disinhibition
- Double vision
- Dulled perception